Hydroxyapatite-collagen composites. Part I: can the decrease of the interactions between the two components be a physicochemical component of osteoporosis in aged bone?

被引:7
作者
Barbani, Niccoletta [2 ]
Rosellini, Elisabetta [2 ]
Cristallini, Caterina [1 ]
Guerra, Giulio D. [1 ]
Krajewski, Adriano [3 ]
Mazzocchi, Mauro [3 ]
机构
[1] CNR, UOS Pisa, IMCB, I-56122 Pisa, Italy
[2] Univ Pisa, Dipartimento Ingn Chim Chim Ind & Sci Mat, I-56122 Pisa, Italy
[3] CNR, ISTEC, I-48018 Faenza, RA, Italy
关键词
POSTMENOPAUSAL WOMEN; FRACTURES; RISK; BISPHOSPHONATES; PREVENTION; JAWS;
D O I
10.1007/s10856-011-4238-2
中图分类号
R318 [生物医学工程];
学科分类号
100103 [病原生物学];
摘要
The interactions of Type I acid soluble collagen (Col) with both carbonate-free hydroxyapatite (HA(1100)) and carbonate-rich one (CHA) were investigated. The aim was to ascertain whether the increase of bone CO3 (2-) with ageing could relate to the disease known as osteoporosis. HA(1100)-Col and CHA-Col composites with various ratios were prepared and examined. Scanning electron microscopy and differential scanning calorimetry showed a stronger adhesion of the Col matrix to the granules of HA(1100) than to those of CHA. FT-IR spectroscopy showed that with HA(1100) both multiple hydrogen bonds of Col peptide -NH groups with HA PO4 (3-), and electrochemical interactions between Col peptide -C=O groups and HA Ca2+ were present. In the presence of CO3 (2-), the interactions between -NH and phosphate were diminished, and Ca2+ interacted more strongly with CO3 (2-) than with peptide -C=O, so causing a separation between the two components of the bone extra-cellular matrix. The results obtained strengthen the hypothesis that the substitution of PO4 (3-) ions by CO3 (2-) ions in the HA lattice might be a significant component of osteoporosis, although further investigation is needed.
引用
收藏
页码:637 / 646
页数:10
相关论文
共 32 条
[1]
BERTONI F, 2006, P 20 EUR C BIOM NANT
[2]
Acid-base imbalance and the skeleton [J].
Bushinsky, DA .
EUROPEAN JOURNAL OF NUTRITION, 2001, 40 (05) :238-244
[3]
Aging bone and cartilage: cross-cutting issues [J].
Carrington, JL .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 328 (03) :700-708
[4]
Recent advances in understanding the mechanism of action of bisphosphonates [J].
Coxon, Fraser P. ;
Thompson, Keith ;
Rogers, Michael J. .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (03) :307-312
[5]
EPSTEIN EH, 1971, J BIOL CHEM, V246, P1718
[6]
Mineral changes in osteoporosis - A review [J].
Faibish, Dan ;
Ott, Susan M. ;
Boskey, Adele L. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2006, (443) :28-38
[7]
Bisphosphonates for Osteoporosis [J].
Favus, Murray J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21) :2027-2035
[8]
Felsenberg D, 2001, Pharm Unserer Zeit, V30, P488, DOI 10.1002/1615-1003(200111)30:6<488::AID-PAUZ488>3.0.CO
[9]
2-U
[10]
GAGLIARDI M, 2008, P 11 M SEM CER CELLS, P182